Log in to save to my catalogue

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3cae62aaeca548e1aca3f8b16fd97d34

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors

About this item

Full title

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors

Publisher

England: Taylor & Francis Ltd

Journal title

Journal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2414382

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis Ltd

More information

Scope and Contents

Contents

Inhibiting apoptosis signal regulated kinase 1 (ASK1) is an attractive strategy for treating diseases such as non-alcoholic steatohepatitis and multiple sclerosis. Here, we report the discovery of a dibromo substituted quinoxaline fragment containing
as an effective small-molecule inhibitor of ASK1, with an IC
value of 30.17 nM. In addition,...

Alternative Titles

Full title

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3cae62aaeca548e1aca3f8b16fd97d34

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3cae62aaeca548e1aca3f8b16fd97d34

Other Identifiers

ISSN

1475-6366,1475-6374

E-ISSN

1475-6374

DOI

10.1080/14756366.2024.2414382

How to access this item